This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
This trust’s own Schedule of Assets is parsed — see the full holdings in the Investments section below.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $822K | — |
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| KPMG LLP | 13-5565207 | — | NONE | $80K | — |
| PI | % of plan | |||||
|---|---|---|---|---|---|---|
| Index Ventures VII LP | Other securities | — | $7.3M | $32.8M | 21.3% | |
| Index Ventures VI | Other securities | — | $3.4M | $17.8M | 11.5% | |
| Pitango Venture Capital Fund VI | Other securities | — | $2.3M | $11.3M | 7.3% | |
| Accel London IV | Other securities | — | $3.0M | $9.0M | 5.9% | |
| JPMorgan US Government Money Market Fund | Cash / Money Market | — | $8.4M | $8.4M | 5.5% | |
| Palamon European Equity III 'A' | Other securities | — | $7.5M | $7.3M | 4.7% | |
| TDR Capital III | Other securities | — | $2.9M | $5.9M | 3.8% | |
| Altor Fund IV | Other securities | — | $5.4M | $5.7M | 3.7% | |
| France Special Situations Fund II | Other securities | — | $10.6M | $5.4M | 3.5% | |
| HitecVision VII | Other securities | — | $9.1M | $5.2M | 3.3% | |
| Aleph | Other securities | — | $2.8M | $4.9M | 3.2% | |
| Affinity Asia Pacific Fund IV | Other securities | — | $4.5M | $4.5M | 2.9% | |
| Oakley Capital Private Equity II-B | Other securities | — | $5.0M | $3.9M | 2.5% | |
| Medicxi Secondary I | Other securities | — | $1.9M | $3.7M | 2.4% | |
| BC European Capital IX | Other securities | — | $5.8M | $3.5M | 2.2% | |
| Prime Ventures IV | Other securities | — | $3.1M | $3.0M | 1.9% | |
| HitecVision VI | Other securities | — | $4.7M | $2.6M | 1.7% | |
| Index Ventures Growth Fund II | Other securities | — | $2.5M | $2.4M | 1.6% | |
| Vitruvian Investment Partnership II-B LP | Other securities | — | $3.9M | $2.3M | 1.5% | |
| Investindustrial V LP | Other securities | — | $4.0M | $2.0M | 1.3% | |
| Nordic Capital VIII Beta | Other securities | — | $4.5M | $1.5M | 1.0% | |
| Palamon European Equity II | Other securities | — | $4.5M | $1.4M | 0.9% | |
| Xilos Co-Investment No. 1 Separate Limited | Common Stock | — | $1.3M | $1.4M | 0.9% | |
| Index Ventures Life VI | Other securities | — | $1.0M | $1.2M | 0.8% | |
| Living Bridge 5 | Other securities | — | $961K | $1.0M | 0.7% | |
| TDR Capital II | Other securities | — | $3.4M | $1.0M | 0.7% | |
| Polish Enterprise Fund VII | Other securities | — | $2.7M | $834K | 0.5% | |
| Advent International GPE VII-E | Other securities | — | $2.6M | $828K | 0.5% | |
| DBAG Fund VI | Other securities | — | $1.8M | $613K | 0.4% | |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Abingworth Bioventures VI | Other securities | — | $1.1M | $576K | 0.4% | |
| Affinity Asia Pacific Fund III | Other securities | — | $8.9M | $520K | 0.3% | |
| Quadrant Private Equity No.4 | Other securities | — | $5K | $334K | 0.2% | |
| Advent International Global Private Equity VI-C | Other securities | — | $1.3M | $225K | 0.1% | |
| Latour Capital I | Other securities | — | $301K | $222K | 0.1% | |
| CVC European Equity Partners V | Other securities | — | $2.1M | $219K | 0.1% | |
| Waterland Private Equity Fund V C.V. | Other securities | — | $40K | $186K | 0.1% | |
| Atlantic and Pacific VI | Other securities | — | $195K | $118K | <0.1% | |
| Archer Capital 5 | Other securities | — | $1.2M | $106K | <0.1% | |
| New Enterprise Associates 12 | Other securities | — | $2.8M | $102K | <0.1% | |
| Charterhouse Capital Partners IX | Other securities | — | $2.2M | $36K | <0.1% | |
| Vitruvian Investment Partnership I | Other securities | — | $104K | $14K | <0.1% | |
| HitecVision V | Other securities | — | $4.2M | $13K | <0.1% | |
| HitecVision SpringPoint LP 0 | Other securities | — | — | $6K | <0.1% | |
| HitecVision SpringPoint LP 0 | Other securities | — | — | $1K | <0.1% |
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| T. ROWE PRICE ASSOCIATES, INC. | 52-0556948 | — | NONE | $21K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $8K | — |
